Security Snapshot

Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) Institutional Ownership

CUSIP: 39868T105

13F Institutional Holders and Ownership History from Q3 2018 to Q4 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
160,529,963
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • GRTS - Gritstone bio, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 39868T105.
  • Latest finished 13F holder period is not available.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1 to 0 between Q3 2025 and Q4 2025.
  • SEC-reported value moved from $4,118 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

39868T105

Latest holder period

n/a

13F holders

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
GRTS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Redmile Group, LLC 8.2% $131,635 13,163,457 Redmile Group, LLC 31 Dec 2024

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
29
Latest
n/a
Rows shown
1-25 of 29
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$4,118 0
2025 Q3 7,101 $4,118 +$4,118 $0.58 1
2025 Q1 0 $0 -$773 0
2024 Q4 68,866 $773 -$20,647,950 $0.01 2
2024 Q3 35,628,372 $20,661,928 -$4,308,184 $0.58 55
2024 Q2 39,212,556 $24,236,603 -$19,716,392 $0.62 75
2024 Q1 46,863,208 $120,418,820 +$12,687,383 $2.57 84
2023 Q4 42,085,723 $85,856,544 -$11,439,635 $2.04 88
2023 Q3 48,612,900 $83,617,044 -$4,320,891 $1.72 88
2023 Q2 50,962,397 $99,490,547 +$7,005,623 $1.95 86
2023 Q1 46,273,450 $128,634,074 +$4,987,326 $2.78 89
2022 Q4 44,081,544 $152,081,792 +$37,336,995 $3.45 89
2022 Q3 33,453,341 $85,974,736 -$4,329,965 $2.57 76
2022 Q2 35,170,357 $85,107,364 -$17,400,543 $2.42 81
2022 Q1 39,953,370 $164,926,021 -$163,393,442 $4.12 112
2021 Q4 49,079,808 $629,881,488 +$66,066,934 $12.86 112
2021 Q3 42,395,927 $458,360,639 +$86,031,471 $10.80 90
2021 Q2 34,818,530 $317,890,500 +$6,996,481 $9.13 99
2021 Q1 34,045,816 $321,066,530 +$42,420,523 $9.43 96
2020 Q4 31,980,460 $126,010,396 +$37,330,969 $3.94 67
2020 Q3 22,817,492 $60,471,300 -$31,865,053 $2.65 64
2020 Q2 29,186,352 $193,788,948 -$4,335,520 $6.64 79
2020 Q1 29,847,520 $173,782,820 +$3,188,518 $5.82 64
2019 Q4 26,131,590 $234,363,395 +$5,808,914 $8.97 55
2019 Q3 28,600,546 $246,958,867 -$1,661,860 $8.64 61
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .